BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20298298)

  • 1. Cessation in the use of tobacco - pharmacologic and non-pharmacologic routines in patients.
    Quist-Paulsen P
    Clin Respir J; 2008 Jan; 2(1):4-10. PubMed ID: 20298298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effective primary care-based strategies to improve smoking cessation: more value for money.
    Salize HJ; Merkel S; Reinhard I; Twardella D; Mann K; Brenner H
    Arch Intern Med; 2009 Feb; 169(3):230-5; discussion 235-6. PubMed ID: 19204212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The number of smokers needed to screen and treat in a smoking cessation programme.
    Storm-Versloot MN; Vermeulen H; Wiggers LC; Smets EM; de Haes HC; Peters RJ; Legemate DA; de Vos R
    Eur J Cardiovasc Prev Rehabil; 2009 Dec; 16(6):669-76. PubMed ID: 19738472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of a minimal contact smoking cessation programme in out-patients with chronic obstructive pulmonary disease: a pre-post-test study.
    Monninkhof E; van der Valk P; van der Palen J; Mulder H; Pieterse M; van Herwaarden C; Zielhuis G
    Patient Educ Couns; 2004 Mar; 52(3):231-6. PubMed ID: 14998591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cost-effectiveness model of smoking cessation based on a randomised controlled trial of varenicline versus placebo in patients with chronic obstructive pulmonary disease.
    Lock K; Wilson K; Murphy D; Riesco JA
    Expert Opin Pharmacother; 2011 Dec; 12(17):2613-26. PubMed ID: 22017336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking cessation intervention: an evidence-based approach.
    Laniado-Laborín R
    Postgrad Med; 2010 Mar; 122(2):74-82. PubMed ID: 20203458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implementing a hospital-based smoking cessation programme: evidence for a learning effect.
    Raupach T; Shahab L; Neubert K; Felten D; Hasenfuss G; Andreas S
    Patient Educ Couns; 2008 Feb; 70(2):199-204. PubMed ID: 18031972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smoking cessation interventions in clinical practice.
    Cornuz J
    Eur J Vasc Endovasc Surg; 2007 Oct; 34(4):397-404. PubMed ID: 17681834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost effectiveness of varenicline versus bupropion and unaided cessation for smoking cessation in a cohort of Finnish adult smokers.
    Linden K; Jormanainen V; Linna M; Sintonen H; Wilson K; Kotomäki T
    Curr Med Res Opin; 2010 Mar; 26(3):549-60. PubMed ID: 20050814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking cessation in a blue-collar population: results from an evidence-based pilot program.
    Ringen K; Anderson N; McAfee T; Zbikowski SM; Fales D
    Am J Ind Med; 2002 Nov; 42(5):367-77. PubMed ID: 12382249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicomponent individualized smoking cessation intervention for patients with lung disease.
    Jonsdottir H; Jonsdottir R; Geirsdottir T; Sveinsdottir KS; Sigurdardottir T
    J Adv Nurs; 2004 Dec; 48(6):594-604. PubMed ID: 15548250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of varenicline for smoking cessation.
    Keiding H
    Expert Rev Pharmacoecon Outcomes Res; 2009 Jun; 9(3):215-21. PubMed ID: 19527093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis of a European primary-care physician training in smoking cessation counseling.
    Pinget C; Martin E; Wasserfallen JB; Humair JP; Cornuz J
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):451-5. PubMed ID: 17568248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of patients with COPD in three motivational stages related to smoking cessation.
    Hilberink SR; Jacobs JE; Schlösser M; Grol RP; de Vries H
    Patient Educ Couns; 2006 Jun; 61(3):449-57. PubMed ID: 16157462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Group therapy and smoking cessation].
    Møller AM; Tønnesen H
    Ugeskr Laeger; 1999 Sep; 161(36):4987-8. PubMed ID: 10489789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tobacco treatment and prevention: what works and why.
    Goodfellow LT; Waugh JB
    Respir Care; 2009 Aug; 54(8):1082-90. PubMed ID: 19650948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking cessation in chronic obstructive pulmonary disease.
    Tashkin DP; Murray RP
    Respir Med; 2009 Jul; 103(7):963-74. PubMed ID: 19285850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of a smoking cessation program in patients admitted for coronary heart disease.
    Quist-Paulsen P; Lydersen S; Bakke PS; Gallefoss F
    Eur J Cardiovasc Prev Rehabil; 2006 Apr; 13(2):274-80. PubMed ID: 16575284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Smoking reduction and temporary abstinence: new approaches for smoking cessation].
    Le Houezec J; Säwe U
    J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking cessation.
    Marlow SP; Stoller JK
    Respir Care; 2003 Dec; 48(12):1238-54; discussion 1254-6. PubMed ID: 14651764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.